Cargando…
Targeting Mitochondrial DNA Transcription by POLRMT Inhibition or Depletion as a Potential Strategy for Cancer Treatment
Transcription of the mitochondrial genome is essential for the maintenance of oxidative phosphorylation (OXPHOS) and other functions directly related to this unique genome. Considerable evidence suggests that mitochondrial transcription is dysregulated in cancer and cancer metastasis and contributes...
Autores principales: | Daglish, Sabrina C. D., Fennell, Emily M. J., Graves, Lee M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295849/ https://www.ncbi.nlm.nih.gov/pubmed/37371693 http://dx.doi.org/10.3390/biomedicines11061598 |
Ejemplares similares
-
POLRMT mutations impair mitochondrial transcription causing neurological disease
por: Oláhová, Monika, et al.
Publicado: (2021) -
Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer
por: Li, Xiaojun, et al.
Publicado: (2023) -
Targeting Mitochondrial Metabolism and RNA Polymerase POLRMT to Overcome Multidrug Resistance in Cancer
por: Yu, Hui-Jing, et al.
Publicado: (2021) -
The mitochondrial RNA polymerase POLRMT promotes skin squamous cell carcinoma cell growth
por: Wang, Yulong, et al.
Publicado: (2022) -
POLRMT regulates the switch between replication primer formation and gene expression of mammalian mtDNA
por: Kühl, Inge, et al.
Publicado: (2016)